戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 egy: a cyclic phosphodiesterase that acts on adenosine diphosphate-ribose 1"-2" cyclic phosphate (App
2 isolated terminals, we tested 8-bromo-cyclic adenosine diphosphate ribose (8Br-cADPr), a competitive
3 ribosyltransferases catalyze the transfer of adenosine diphosphate ribose (ADP-ribose) from nicotinam
4 brane protein that converts NAD primarily to adenosine diphosphate ribose (ADPR) and a small amount o
5                     It metabolizes NAD(+) to adenosine diphosphate ribose (ADPR) and cyclic ADPR, reg
6          However, these enzymes also produce adenosine diphosphate ribose (ADPR) and nicotinic acid a
7 where, involves the release of mitochondrial adenosine diphosphate ribose (ADPR) or nicotinamide aden
8             It is activated by intracellular adenosine diphosphate ribose (ADPR) through a diphosphor
9 this strategy should be applicable to cyclic adenosine diphosphate ribose and nicotinic acid adenine
10 PM2 channels were activated by intracellular adenosine diphosphate-ribose and blocked by flufenamic a
11 f two potent Ca(2+) releasing agents: cyclic adenosine diphosphate ribose (cADPR) from nicotinamide a
12 of the calcium-mobilizing metabolite, cyclic adenosine diphosphate ribose (cADPR), from nicotinamide
13 e ribose (ADPR) and a small amount of cyclic adenosine diphosphate ribose (cADPR).
14 k incorporates the signaling molecule cyclic adenosine diphosphate ribose (cADPR).
15 ates the cytosolic signaling molecule cyclic adenosine diphosphate ribose (cADPR).
16                       Blockade of the cyclic adenosine diphosphate ribose (cADPR)/ryanodine-sensitive
17 sitol 1,4,5-trisphosphate (IP(3)) and cyclic adenosine diphosphate-ribose (cADPR) are second messenge
18 parks was increased by calmodulin and cyclic adenosine diphosphate-ribose (cADPR).
19 ng agents sphingosine-1-phosphate and cyclic adenosine diphosphate ribose exhibited weaker ABA-stimul
20 ial growth factor, 3-nitrotyrosine, and poly(adenosine diphosphate ribose) expression in lung tissue.
21 ) resulting in the generation of polymers of adenosine diphosphate-ribose (PAR).
22  ROS), 3-nitrotyrosine (marker of RNS), poly(adenosine diphosphate-ribose) (PAR, marker of PARP activ
23 of caspase-2 and caspase-3, cleavage of poly(adenosine diphosphate-ribose) (poly(ADP-ribose)) polymer
24 accompanied by caspase-3 activation and poly-adenosine diphosphate ribose polymerase (PARP) cleavage
25 age during transplantation can activate poly-adenosine diphosphate ribose polymerase (PARP) resulting
26 on stress, a defect accentuated by poly-ADP (adenosine diphosphate) ribose polymerase inhibitors.
27            Similarly, the NAD-dependent poly(adenosine diphosphate)ribose polymerase 1 (PARP1) may af
28 rial dysfunction, caspase cleavage, and poly adenosine diphosphate-ribose polymerase (PARP) degradati
29 by caspase-8, -9, and -3 and PARP (poly-ADP [adenosine diphosphate]-ribose polymerase) cleavage and d
30 NBC has rationalized clinical trials of poly(adenosine diphosphate ribose) polymerase (PARP) inhibito
31          Caspase activity, measured by poly (adenosine diphosphate ribose) polymerase (PARP) proteoly
32 ired IHHs displayed caspase activation, poly(adenosine diphosphate ribose) polymerase cleavage, and a
33     In cells deficient in the telomeric poly(adenosine diphosphate ribose) polymerase tankyrase 1, si
34 noblots demonstrated adaphostin induced poly(adenosine diphosphate-ribose) polymerase (PARP) cleavage
35 ected by caspases-3 and -8 cleavage and poly(adenosine diphosphate-ribose) polymerase (PARP) degradat
36  a rational target for therapy based on poly(adenosine diphosphate-ribose) polymerase (PARP) inhibiti
37                                         Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibito
38 ated the effects of a novel ultrapotent poly(adenosine diphosphate-ribose) polymerase (PARP) inhibito
39 ding DNA fragmentation and cleavage of poly (adenosine diphosphate-ribose) polymerase (PARP), as well
40 ankyrins and to the catalytic domain of poly(adenosine diphosphate-ribose) polymerase (PARP), was ide
41 f caspase-3, -8, and -9 and cleavage of poly(adenosine diphosphate-ribose) polymerase (PARP).
42 gen species (RNS) and the activation of poly(adenosine diphosphate-ribose) polymerase (PARP).
43  the human bax promoter and found that poly (adenosine diphosphate-ribose) polymerase 1 recruited the
44  mitochondrial membrane potential, and poly (adenosine diphosphate-ribose) polymerase cleavage.
45 C-alpha, phospho-PKC-beta1, and cleaved poly(adenosine diphosphate-ribose) polymerase in post-CP/Rep
46 HR) as measured by hypersensitivity to poly (adenosine diphosphate-ribose) polymerase inhibition and
47 high tidal volume ventilation plus the poly-(adenosine diphosphate-ribose) polymerase inhibitor 3-ami
48 e II prospective clinical trial of the poly-(adenosine diphosphate-ribose) polymerase inhibitor olapa
49 nstability in response to radiation and poly(adenosine diphosphate-ribose) polymerase inhibitors, com
50  cyclin-dependent kinase inhibitors and poly(adenosine diphosphate-ribose) polymerase inhibitors.
51 ospho-PKC-alpha, phospho-PKC-beta1, and poly(adenosine diphosphate-ribose) polymerase were quantified
52 actor, caspase 3, caspase 8, caspase 9, poly(adenosine diphosphate-ribose) polymerase, B-cell lymphom
53                Subsequent to the break, poly(adenosine diphosphate-ribose) polymerase-1 enzymatic act
54 activity of caspase-3/7 and cleavage of poly(adenosine diphosphate-ribose) polymerase.
55 r 1) prevents it from inhibiting PARP1 [poly(adenosine diphosphate-ribose) polymerase], a critical DN
56 luorthanatrace (FTT) depicts activated poly (adenosine diphosphate-ribose)polymerase (PARP) expressio
57                                     The poly(adenosine diphosphate-ribose)polymerase (PARP) family of
58 ed forms of caspases-2 and -3, bax, and poly-adenosine diphosphate-ribose-polymerase (PARP) by Wester
59 ), enhanced cell death (caspase 3/7 and poly[adenosine diphosphate-ribose] polymerase activity, chrom
60 an essential substrate for sirtuins and poly(adenosine diphosphate-ribose) polymerases (PARPs), which
61  other enzymes such as the sirtuins and poly(adenosine diphosphate-ribose) polymerases.
62 entification of an unexpected molecule, poly(adenosine diphosphate ribose), that may be implicated in

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。